ReviewJournal for immunotherapy of cancer2020

Current evidence and future perspectives of immune-checkpoint inhibitors in unresectable malignant pleural mesothelioma.

Katsuyuki Hotta et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.